{"id":3702,"date":"2026-09-28T12:00:46","date_gmt":"2026-09-28T12:00:46","guid":{"rendered":"https:\/\/ebram.com\/?p=3702"},"modified":"2026-09-28T12:15:04","modified_gmt":"2026-09-28T12:15:04","slug":"doencas-cardiovasculares","status":"publish","type":"post","link":"https:\/\/ebram.com\/en\/doencas-cardiovasculares\/","title":{"rendered":"Major Cardiovascular Diseases in Brazil: Understanding the Risks, Management, and Importance of Screenings"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"3702\" class=\"elementor elementor-3702\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2a4e878b e-flex e-con-boxed e-con e-parent\" data-id=\"2a4e878b\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1a380e7 elementor-widget elementor-widget-text-editor\" data-id=\"1a380e7\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"ui-typography-paragraph\">As doen\u00e7as cardiovasculares est\u00e3o entre os principais desafios de sa\u00fade p\u00fablica no Brasil e no mundo. Elas envolvem condi\u00e7\u00f5es que afetam o cora\u00e7\u00e3o e os vasos sangu\u00edneos e podem evoluir de forma silenciosa por anos, at\u00e9 provocar eventos graves, como infarto e acidente vascular cerebral (AVC).<\/p><p class=\"ui-typography-paragraph\">No Brasil, as doen\u00e7as cardiovasculares permanecem como uma das principais causas de morte. Dados do Minist\u00e9rio da Sa\u00fade apontam que essas doen\u00e7as respondem por cerca de 400 mil \u00f3bitos por ano no pa\u00eds, refor\u00e7ando a import\u00e2ncia da preven\u00e7\u00e3o, do diagn\u00f3stico e do acompanhamento dos fatores de risco cardiovascular.\u00a0<\/p><p class=\"ui-typography-paragraph\">Diante desse cen\u00e1rio, entender como funciona o sistema cardiovascular, conhecer as principais doen\u00e7as e acompanhar os fatores de risco \u00e9 fundamental para a preven\u00e7\u00e3o e o controle.<\/p><p><b class=\"ui-typography-text-bold\">Quais s\u00e3o as principais doen\u00e7as cardiovasculares?<\/b><\/p><p>As doen\u00e7as cardiovasculares n\u00e3o correspondem a uma \u00fanica condi\u00e7\u00e3o. O grupo inclui diferentes doen\u00e7as que podem comprometer o cora\u00e7\u00e3o ou os vasos sangu\u00edneos.<\/p><p class=\"ui-typography-paragraph\"><b class=\"ui-typography-text-bold\">1. Hipertens\u00e3o arterial<\/b><\/p><p class=\"ui-typography-paragraph\">\u00c9 uma condi\u00e7\u00e3o especialmente importante porque pode permanecer sem sintomas durante muito tempo. Quando n\u00e3o controlada, aumenta o risco de complica\u00e7\u00f5es como infarto, AVC, insufici\u00eancia card\u00edaca e doen\u00e7a renal.<\/p><p class=\"ui-typography-paragraph\">Por ser frequentemente silenciosa, a aferi\u00e7\u00e3o regular da press\u00e3o arterial \u00e9 fundamental para identificar altera\u00e7\u00f5es.<\/p><p class=\"ui-typography-paragraph\"><b class=\"ui-typography-text-bold\">2. Doen\u00e7a arterial coronariana e infarto<\/b><\/p><p class=\"ui-typography-paragraph\">A doen\u00e7a arterial coronariana ocorre quando as art\u00e9rias que levam sangue ao m\u00fasculo card\u00edaco s\u00e3o comprometidas, geralmente pela forma\u00e7\u00e3o e progress\u00e3o de placas de aterosclerose.<\/p><p class=\"ui-typography-paragraph\">Quando o fluxo sangu\u00edneo para o cora\u00e7\u00e3o \u00e9 significativamente reduzido ou interrompido, pode ocorrer o <b class=\"ui-typography-text-bold\">infarto agudo do mioc\u00e1rdio<\/b>.<\/p><p class=\"ui-typography-paragraph\">Entre os fatores associados est\u00e3o hipertens\u00e3o, colesterol elevado, diabetes, tabagismo, excesso de peso, sedentarismo e hist\u00f3rico familiar.<\/p><p class=\"ui-typography-paragraph\">Em situa\u00e7\u00f5es de suspeita de les\u00e3o card\u00edaca, exames laboratoriais podem contribuir para a avalia\u00e7\u00e3o do paciente. Marcadores como troponina e CK-MB s\u00e3o utilizados na investiga\u00e7\u00e3o de les\u00e3o do m\u00fasculo card\u00edaco, sempre em conjunto com a avalia\u00e7\u00e3o cl\u00ednica e outros exames.<\/p><p class=\"ui-typography-paragraph\"><b class=\"ui-typography-text-bold\">3. Acidente vascular cerebral (AVC)<\/b><\/p><p class=\"ui-typography-paragraph\">O AVC acontece quando o fluxo de sangue para uma regi\u00e3o do c\u00e9rebro \u00e9 interrompido ou quando ocorre um sangramento dentro ou ao redor do c\u00e9rebro.<\/p><p class=\"ui-typography-paragraph\">No AVC isqu\u00eamico, a interrup\u00e7\u00e3o est\u00e1 relacionada \u00e0 obstru\u00e7\u00e3o de um vaso. J\u00e1 no AVC hemorr\u00e1gico ocorre o rompimento de um vaso sangu\u00edneo.<\/p><p class=\"ui-typography-paragraph\">Entre os principais fatores associados est\u00e3o hipertens\u00e3o, diabetes, colesterol elevado, excesso de peso, tabagismo, sedentarismo e idade avan\u00e7ada.<\/p><p class=\"ui-typography-paragraph\">O controle desses fatores \u00e9 uma das principais estrat\u00e9gias para reduzir o risco de ocorr\u00eancia.<\/p><p class=\"ui-typography-paragraph\"><b class=\"ui-typography-text-bold\">4. Insufici\u00eancia card\u00edaca<\/b><\/p><p class=\"ui-typography-paragraph\">A insufici\u00eancia card\u00edaca ocorre quando o cora\u00e7\u00e3o n\u00e3o consegue bombear sangue de maneira suficiente para atender \u00e0s necessidades do organismo.<\/p><p class=\"ui-typography-paragraph\">Ela pode estar relacionada a diferentes doen\u00e7as cardiovasculares, incluindo hipertens\u00e3o arterial, doen\u00e7a coronariana e altera\u00e7\u00f5es das v\u00e1lvulas card\u00edacas.<\/p><p class=\"ui-typography-paragraph\">O acompanhamento cont\u00ednuo \u00e9 importante para identificar altera\u00e7\u00f5es, controlar os fatores associados e acompanhar a evolu\u00e7\u00e3o da condi\u00e7\u00e3o.<\/p><p class=\"ui-typography-paragraph\"><b class=\"ui-typography-text-bold\">5. Arritmias card\u00edacas<\/b><\/p><p class=\"ui-typography-paragraph\">As arritmias s\u00e3o altera\u00e7\u00f5es no ritmo dos batimentos do cora\u00e7\u00e3o. O cora\u00e7\u00e3o pode bater de maneira muito r\u00e1pida, muito lenta ou de forma irregular.<\/p><p class=\"ui-typography-paragraph\">Algumas arritmias s\u00e3o benignas, enquanto outras podem aumentar o risco de complica\u00e7\u00f5es cardiovasculares. A fibrila\u00e7\u00e3o atrial, por exemplo, est\u00e1 associada a um maior risco de AVC.<\/p><p class=\"ui-typography-paragraph\">A investiga\u00e7\u00e3o pode envolver avalia\u00e7\u00e3o cl\u00ednica, eletrocardiograma, monitoriza\u00e7\u00e3o do ritmo card\u00edaco e outros exames, conforme a necessidade de cada paciente.<\/p><p class=\"ui-typography-paragraph\"><b class=\"ui-typography-text-bold\">Quais s\u00e3o os principais fatores de risco cardiovascular?<\/b><\/p><p class=\"ui-typography-paragraph\">O desenvolvimento das doen\u00e7as cardiovasculares est\u00e1 relacionado a uma combina\u00e7\u00e3o de fatores gen\u00e9ticos, metab\u00f3licos, comportamentais e ambientais.<\/p><p class=\"ui-typography-paragraph\">Entre os principais est\u00e3o:<\/p><ul class=\"ui-typography-ul\"><li class=\"ui-typography-li\">Hipertens\u00e3o arterial;<\/li><li class=\"ui-typography-li\">Colesterol e outros lip\u00eddios elevados;<\/li><li class=\"ui-typography-li\">Diabetes e glicemia elevada;<\/li><li class=\"ui-typography-li\">Sobrepeso e obesidade;<\/li><li class=\"ui-typography-li\">Tabagismo;<\/li><li class=\"ui-typography-li\">Sedentarismo;<\/li><li class=\"ui-typography-li\">Alimenta\u00e7\u00e3o inadequada;<\/li><li class=\"ui-typography-li\">Consumo excessivo de \u00e1lcool;<\/li><li class=\"ui-typography-li\">Hist\u00f3rico familiar;<\/li><li class=\"ui-typography-li\">Idade;<\/li><li class=\"ui-typography-li\">Estresse e outros fatores relacionados ao estilo de vida.<\/li><\/ul><p class=\"ui-typography-paragraph\">A OMS destaca que altera\u00e7\u00f5es na <b class=\"ui-typography-text-bold\">press\u00e3o arterial, glicemia, lip\u00eddios sangu\u00edneos e peso corporal<\/b> funcionam como importantes indicadores de risco cardiovascular e podem ser acompanhadas nos servi\u00e7os de sa\u00fade.<\/p><p class=\"ui-typography-paragraph\">Esse acompanhamento \u00e9 importante porque muitos desses fatores podem ser identificados antes que aconte\u00e7a um evento cardiovascular.<\/p><p><b class=\"ui-typography-text-bold\">Ebram e o acompanhamento cardiovascular<\/b><\/p><p class=\"ui-typography-paragraph\">O acompanhamento das doen\u00e7as cardiovasculares exige uma vis\u00e3o integrada dos diferentes fatores que podem influenciar a sa\u00fade do cora\u00e7\u00e3o e dos vasos.<\/p><p class=\"ui-typography-paragraph\">Nesse contexto, os exames laboratoriais t\u00eam papel importante na identifica\u00e7\u00e3o de altera\u00e7\u00f5es metab\u00f3licas, no acompanhamento de fatores de risco e na investiga\u00e7\u00e3o de eventos cardiovasculares.<\/p><p class=\"ui-typography-paragraph\">A Ebram conta com reagentes da <b class=\"ui-typography-text-bold\"><a href=\"https:\/\/ebram.com\/en\/reagente\/bioquimica\/\">Linha Bioqu\u00edmica<\/a>, <a href=\"https:\/\/ebram.com\/en\/reagente\/turbidimetria\/\">Turbidimetry<\/a> e <a href=\"https:\/\/ebram.com\/en\/reagente\/testes-rapidos\/\">Quick Tests<\/a><\/b> que podem compor avalia\u00e7\u00f5es relacionadas \u00e0 sa\u00fade cardiovascular.<\/p><p class=\"ui-typography-paragraph\">No perfil lip\u00eddico, est\u00e3o dispon\u00edveis reagentes para <b class=\"ui-typography-text-bold\"><a href=\"https:\/\/ebram.com\/en\/reagente\/bioquimica\/#colesterol\">Colesterol Total<\/a>, <a href=\"https:\/\/ebram.com\/en\/reagente\/bioquimica\/#triglicerides\">Triglycerides<\/a> e <a href=\"https:\/\/ebram.com\/en\/reagente\/bioquimica\/#hdl-colesterol\">HDL-colesterol<\/a><\/b>. J\u00e1 no perfil card\u00edaco, a Ebram disponibiliza <b class=\"ui-typography-text-bold\"><a href=\"https:\/\/ebram.com\/en\/reagente\/bioquimica\/#cknac\">CK Total<\/a>, <a href=\"https:\/\/ebram.com\/en\/reagente\/bioquimica\/#ckmb\">CK-MB<\/a>, <a href=\"https:\/\/ebram.com\/en\/reagente\/testes-rapidos\/#troponina-i\">Troponin I<\/a> e <a href=\"https:\/\/ebram.com\/en\/reagente\/turbidimetria\/#pcr-ultra-sensivel\">PCR Ultrassens\u00edvel<\/a><\/b>.<\/p><p class=\"ui-typography-paragraph\">S\u00e3o diferentes marcadores, com diferentes aplica\u00e7\u00f5es, que fazem parte de estrat\u00e9gias de acompanhamento e investiga\u00e7\u00e3o cardiovascular.<\/p><p class=\"ui-typography-paragraph\"><b class=\"ui-typography-text-bold\">A <a href=\"https:\/\/ebram.com\/en\/\">Ebram<\/a> oferece reagentes para diferentes avalia\u00e7\u00f5es relacionadas ao perfil cardiovascular, apoiando o trabalho dos profissionais de sa\u00fade e a realiza\u00e7\u00e3o dos exames que fazem parte desse acompanhamento.<\/b><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>As doen\u00e7as cardiovasculares est\u00e3o entre os principais desafios de sa\u00fade p\u00fablica no Brasil e no mundo. Elas envolvem condi\u00e7\u00f5es que afetam o cora\u00e7\u00e3o e os vasos sangu\u00edneos e podem evoluir de forma silenciosa por anos, at\u00e9 provocar eventos graves, como infarto e acidente vascular cerebral (AVC). No Brasil, as doen\u00e7as cardiovasculares permanecem como uma das [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":3712,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[216,55,117,294,361],"class_list":["post-3702","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-pt","tag-bioquimica-ebram","tag-lancamento","tag-linha-bioquimica","tag-linha-de-turbidimetria","tag-testes-rapidos"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Conhe\u00e7a o novo reagente QUIMIFRU Frutosamina Ebram<\/title>\n<meta name=\"description\" content=\"A Ebram apresenta o QUIMIFRU frutosamina, novo monorreagente da Linha de Bioqu\u00edmica para o monitoramento glic\u00eamico.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ebram.com\/en\/doencas-cardiovasculares\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conhe\u00e7a o novo reagente QUIMIFRU Frutosamina Ebram\" \/>\n<meta property=\"og:description\" content=\"A Ebram apresenta o QUIMIFRU frutosamina, novo monorreagente da Linha de Bioqu\u00edmica para o monitoramento glic\u00eamico.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ebram.com\/en\/doencas-cardiovasculares\/\" \/>\n<meta property=\"og:site_name\" content=\"Ebram - Produtos Laboratoriais\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-28T12:00:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-28T12:15:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ebram.com\/wp-content\/uploads\/2026\/09\/Ebram_Header_Blog_Set26_V2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"584\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing Ebram\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing Ebram\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ebram.com\/doencas-cardiovasculares\/\",\"url\":\"https:\/\/ebram.com\/doencas-cardiovasculares\/\",\"name\":\"Conhe\u00e7a o novo reagente QUIMIFRU Frutosamina Ebram\",\"isPartOf\":{\"@id\":\"https:\/\/ebram.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ebram.com\/doencas-cardiovasculares\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ebram.com\/doencas-cardiovasculares\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ebram.com\/wp-content\/uploads\/2026\/09\/Ebram_Header_Blog_Set26_V2.jpg\",\"datePublished\":\"2026-09-28T12:00:46+00:00\",\"dateModified\":\"2026-09-28T12:15:04+00:00\",\"author\":{\"@id\":\"https:\/\/ebram.com\/#\/schema\/person\/6d25dfbdd7a1d8da57f9a083eff5849d\"},\"description\":\"A Ebram apresenta o QUIMIFRU frutosamina, novo monorreagente da Linha de Bioqu\u00edmica para o monitoramento glic\u00eamico.\",\"breadcrumb\":{\"@id\":\"https:\/\/ebram.com\/doencas-cardiovasculares\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ebram.com\/doencas-cardiovasculares\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ebram.com\/doencas-cardiovasculares\/#primaryimage\",\"url\":\"https:\/\/ebram.com\/wp-content\/uploads\/2026\/09\/Ebram_Header_Blog_Set26_V2.jpg\",\"contentUrl\":\"https:\/\/ebram.com\/wp-content\/uploads\/2026\/09\/Ebram_Header_Blog_Set26_V2.jpg\",\"width\":900,\"height\":584,\"caption\":\"doen\u00e7as cardiovasculares\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ebram.com\/doencas-cardiovasculares\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ebram.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Principais doen\u00e7as cardiovasculares no Brasil: entenda os riscos, o controle e a import\u00e2ncia dos exames\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ebram.com\/#website\",\"url\":\"https:\/\/ebram.com\/\",\"name\":\"Ebram - Produtos Laboratoriais\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ebram.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ebram.com\/#\/schema\/person\/6d25dfbdd7a1d8da57f9a083eff5849d\",\"name\":\"Marketing Ebram\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ebram.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4ddb138500d98fc0e57c480b17ba26ed84b8d4e0a61fabff540bb8fcfe10131a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4ddb138500d98fc0e57c480b17ba26ed84b8d4e0a61fabff540bb8fcfe10131a?s=96&d=mm&r=g\",\"caption\":\"Marketing Ebram\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conhe\u00e7a o novo reagente QUIMIFRU Frutosamina Ebram","description":"A Ebram apresenta o QUIMIFRU frutosamina, novo monorreagente da Linha de Bioqu\u00edmica para o monitoramento glic\u00eamico.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ebram.com\/en\/doencas-cardiovasculares\/","og_locale":"en_US","og_type":"article","og_title":"Conhe\u00e7a o novo reagente QUIMIFRU Frutosamina Ebram","og_description":"A Ebram apresenta o QUIMIFRU frutosamina, novo monorreagente da Linha de Bioqu\u00edmica para o monitoramento glic\u00eamico.","og_url":"https:\/\/ebram.com\/en\/doencas-cardiovasculares\/","og_site_name":"Ebram - Produtos Laboratoriais","article_published_time":"2026-09-28T12:00:46+00:00","article_modified_time":"2026-09-28T12:15:04+00:00","og_image":[{"width":900,"height":584,"url":"https:\/\/ebram.com\/wp-content\/uploads\/2026\/09\/Ebram_Header_Blog_Set26_V2.jpg","type":"image\/jpeg"}],"author":"Marketing Ebram","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing Ebram","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ebram.com\/doencas-cardiovasculares\/","url":"https:\/\/ebram.com\/doencas-cardiovasculares\/","name":"Conhe\u00e7a o novo reagente QUIMIFRU Frutosamina Ebram","isPartOf":{"@id":"https:\/\/ebram.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ebram.com\/doencas-cardiovasculares\/#primaryimage"},"image":{"@id":"https:\/\/ebram.com\/doencas-cardiovasculares\/#primaryimage"},"thumbnailUrl":"https:\/\/ebram.com\/wp-content\/uploads\/2026\/09\/Ebram_Header_Blog_Set26_V2.jpg","datePublished":"2026-09-28T12:00:46+00:00","dateModified":"2026-09-28T12:15:04+00:00","author":{"@id":"https:\/\/ebram.com\/#\/schema\/person\/6d25dfbdd7a1d8da57f9a083eff5849d"},"description":"A Ebram apresenta o QUIMIFRU frutosamina, novo monorreagente da Linha de Bioqu\u00edmica para o monitoramento glic\u00eamico.","breadcrumb":{"@id":"https:\/\/ebram.com\/doencas-cardiovasculares\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ebram.com\/doencas-cardiovasculares\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ebram.com\/doencas-cardiovasculares\/#primaryimage","url":"https:\/\/ebram.com\/wp-content\/uploads\/2026\/09\/Ebram_Header_Blog_Set26_V2.jpg","contentUrl":"https:\/\/ebram.com\/wp-content\/uploads\/2026\/09\/Ebram_Header_Blog_Set26_V2.jpg","width":900,"height":584,"caption":"doen\u00e7as cardiovasculares"},{"@type":"BreadcrumbList","@id":"https:\/\/ebram.com\/doencas-cardiovasculares\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ebram.com\/"},{"@type":"ListItem","position":2,"name":"Principais doen\u00e7as cardiovasculares no Brasil: entenda os riscos, o controle e a import\u00e2ncia dos exames"}]},{"@type":"WebSite","@id":"https:\/\/ebram.com\/#website","url":"https:\/\/ebram.com\/","name":"Ebram - Laboratory Products","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ebram.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ebram.com\/#\/schema\/person\/6d25dfbdd7a1d8da57f9a083eff5849d","name":"Ebram Marketing","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ebram.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4ddb138500d98fc0e57c480b17ba26ed84b8d4e0a61fabff540bb8fcfe10131a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4ddb138500d98fc0e57c480b17ba26ed84b8d4e0a61fabff540bb8fcfe10131a?s=96&d=mm&r=g","caption":"Marketing Ebram"}}]}},"_links":{"self":[{"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/posts\/3702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/comments?post=3702"}],"version-history":[{"count":15,"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/posts\/3702\/revisions"}],"predecessor-version":[{"id":3718,"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/posts\/3702\/revisions\/3718"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/media\/3712"}],"wp:attachment":[{"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/media?parent=3702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/categories?post=3702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ebram.com\/en\/wp-json\/wp\/v2\/tags?post=3702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}